Co-Authors
                            
                            
                                This is a "connection" page, showing publications co-authored by   Chun Chao   and   Quyen Ngo-Metzger.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            1.301
         
        
        
     
 
    
        
        - 
            A pragmatic randomized trial to compare strategies for implementing?primary HPV testing for routine cervical cancer screening in a large?healthcare system. Implement Sci. 2025 May 12; 20(1):21.
            
            
                Score: 0.245
            
         
        
        - 
            Evaluating the trend of time to colposcopy follow-up among women with a positive primary human papillomavirus screening result at Kaiser Permanente Southern California. Am J Obstet Gynecol. 2025 Mar 27.
            
            
                Score: 0.243
            
         
        
        - 
            Primary Human Papillomavirus Screening: Women's Perceptions of New Cervical Cancer Screening Recommendations. J Womens Health (Larchmt). 2024 Dec; 33(12):1614-1624.
            
            
                Score: 0.234
            
         
        
        - 
            A study protocol for a cluster randomized pragmatic trial for comparing strategies for implementing primary HPV testing for routine cervical cancer screening in a large health care system. Contemp Clin Trials. 2023 01; 124:106994.
            
            
                Score: 0.206
            
         
        
        - 
            De-implementation and substitution of clinical care processes: stakeholder perspectives on the transition to primary human papillomavirus (HPV) testing for cervical cancer screening. Implement Sci Commun. 2021 Sep 23; 2(1):108.
            
            
                Score: 0.191
            
         
        
        - 
            Impact of COVID-19 on Cervical Cancer Screening Rates Among Women Aged 21-65 Years in a Large Integrated Health Care System - Southern California, January 1-September 30, 2019, and January 1-September 30, 2020. MMWR Morb Mortal Wkly Rep. 2021 Jan 29; 70(4):109-113.
            
            
                Score: 0.182